Biomarkers in Late Stage Clinical Trials
The Future of the Biologicals Market
Building Biotech Technology Transfer Opportunities
The Future of the Biodefense Industry: Regulation, funding opportunities & company profiles
Expanding Applications of Personalized Medicine
Biotech Exit Strategies: Delivering value to investors in a challenging funding market
The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
Negotiating the Emerging Biosimilars Landscape
Delivery Mechanisms for Large Molecule Drugs
Leading Drug Delivery Companies and Technologies
The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
Impact of Pharmacogenomics on Public Healthcare Policy
The Future of Biosimilars: Key opportunities & emerging therapies  
The Biotechnology Market Outlook
The Top 10 Biotechnology Companies
Emerging Drug Discovery Technologies
The Future of Personalized Medicine
Pharmaceutical and Biotech Growth Strategies: Future drivers and opportunities
Winning Pharmaceutical R&D Strategies
The Pharmacoeconomics Outlook: Turning value-for-money requirements into a competitive advantage
The Therapeutic Proteins Outlook To 2007
Winning Drug Delivery Strategies: Maximising product performance through new technologies
The Outlook For The Biotech Sector In The Post-Genomic Era
Pharmaceutical R&D Outsourcing Strategies: An analysis of market drivers and resistors to 2010
Next Generation Drugs: Acceleration Through Innovation
The Genomics Outlook To 2005: Transforming pharmaceutical and diagnostic markets
Opportunities in R&D 2001
The Drug Delivery Outlook 2001
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
The Pharmacogenomics Outlook
Integrating Genomics: The Next Generation
The Drug Delivery Outlook to 2005



SALES AND MARKETING
Opportunities in Emerging Pharma Markets
Pharmaceutical Sales Force Effectiveness Strategies
The Promotional Landscape in US and Europe
Launching Combination Products: Brand extension and franchise development strategies
Winning Product Launch Strategies
Indication Expansion: Opportunities for successful lifecycle management
Winning Pharmaceutical Brand Management
Pharmaceutical Branding Strategies
Pharmaceutical Sales Force Strategies
The Pharmaceutical CRM Outlook: Optimizing returns from operational and analytical CRM
Winning Product Launch Strategies
The Pharmaceutical Sales Force Outlook
The DTC Marketing Outlook
The Evolution of DTC marketing across key pharmaceutical markets

GENERICS FOCUS
The Future of the Generics Industry: Opportunities, threats and key trends
Trends in Generics Industry Ownership
Generics Growth Strategies: Cost containment and M&A shape the global generics industry
The Top 10 Generic Pharmaceutical Companies: Positioning, performance and SWOT analyses
Future Growth Opportunities in Generics
The Top 10 Generics Companies
Growth Strategies in Generics: Innovative and aggressive strategies and their impact...
Generics Defense Strategies
The Biogenerics Market Outlook
The European Generics Outlook
The Pharmaceutical Parallel Trade Outlook
The Generics Outlook 2001
The Global Parallel Trade Outlook 2001 - 2006: A Country-by-Country Analysis
Generic Pharmaceutical Outlook 1998-2008

PORTFOLIO AND LIFECYCLE MANAGEMENT
The OTC Pharmaceutical Market in Emerging Countries
OTC Opportunities in Europe, the US and Japan
Optimizing Lifecycle Management
Patent Protection Strategies: Maximising product Revenues
Lifecycle Management Strategies
Pharmaceutical Project and Portfolio Management
Rx-To-OTC Switching Strategies
Patent Protection Strategies: Maximizing market exclusivity
The Pharmaceutical Portfolio Management Outlook
The OTC Outlook to 2007: Extending revenue streams and product lifecycles after patent expiry
Achieving Market Dominance Through Reformulation: A Strategic Insight
Maximising the Drug Lifecycle
The Blockbuster Drugs Outlook: Optimum management strategies throughout the product lifecycle
The Pharmaceutical OTC Market to 2010

REGULATION
Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
Drug Safety in the Post-Vioxx Era
Pharma Market Authorization Strategies
Pharmaceutical Regulatory Affairs Outlook 2002: International strategies for faster drug approval
Regulatory Affairs: Paths to Approval

PHARMACEUTICAL INTELLIGENCE
The Impact of US Healthcare Reform on Pharma
Pricing & Reimbursement in Emerging Markets
The Funding Landscape for Small Biopharma Ventures, 2010–2015
The Australian Pharmaceutical Market Outlook to 2015
The South Korean Pharmaceutical Market Outlook to 2014
Business Intelligence in the Pharmaceutical Market
The Top 10 Pharmaceutical Companies in Latin America
The Private Health Insurance Market in Europe
The Lifestyle Disorders Market Outlook to 2014
The Russian Pharmaceutical Market Outlook to 2014
The South African Pharmaceutical Market Outlook to 2014
The Specialty Pharmaceutical Market Outlook
The Top 10 Eastern European Pharmaceutical Companies
Opportunities in Orphan Drugs
The Turkish Pharmaceutical Market Outlook to 2014
The Middle Eastern Pharmaceutical Market Outlook To 2014
Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution
The Top 10 Pharmaceutical Companies in India
The Chinese Hospital Pharmaceutical Market Outlook To 2014
The Indian Pharmaceutical Market Outlook To 2014
The US Pharmaceutical Market Outlook To 2014: Market trends, leading players and forecasts
The Eastern European Pharmaceutical Market Outlook To 2014
The Asian Cardiovascular Market Outlook to 2014
The Canadian Pharmaceutical Market Outlook to 2013
The Scandinavian Pharmaceutical Market Outlook to 2013
Technology Transfer Strategies: Maximizing the returns from new technologies
The Pharmaceutical Market Outlook to 2018
The Top Ten Specialty Pharmaceutical Companies: Positioning, performance and SWOT analyses
Obesity Drug Markets in the US and EU: Analysis of product pipelines and the competitive environment
Emerging Pharmaceutical Markets
The Indian Pharmaceutical Market to 2011
The Women's Health Market Outlook to 2011
Innovation in Drug Delivery
The Specialty Pharma Market Outlook
Pharmaceutical Growth Opportunities in Brazil, Russia, India and China
Exploiting Pharmaceutical Growth Opportunities in Central and Eastern Europe
The Pharmaceutical Market Outlook to 2015
Pharmaceutical Anti-Counterfeiting Strategies
Beyond the Blockbuster Drug
The Women's Health Outlook to 2008
The Pharmaceutical Market Outlook To 2010: Essential Analysis of Key Drivers of Change
The Blockbuster Drug Outlook To 2007
The Blockbuster Drugs Reference: Product and company analysis
Pharmaceutical Innovation: An analysis of leading companies and strategies
The Pharmaceutical Industry Paradox
Strategic Intelligence: The Top 12 Pharmaceutical Companies
Global Orthopaedic Markets: Bridging the Divide
The Pharmaceutical industry in the 21st Century
Top Ten and Emerging Pharmaceutical markets
The US Healthcare Market into the 21st Century
The Pharmaceutical Distribution Outlook 1998-2008
Global Pharmaceutical: a market, company and disease analysis
Healthcare Informatics: into the 21st Century
The Pharmaceutical Profitability Outlook
Managed Care in Global Healthcare Markets

STRATEGIC ALLIANCES AND M&A
The Evolving Pharma M&A Landscape: Emerging trends and predicted post-blockbuster targets
Evolving Trends in Biopharmaceutical Licensing
Biotech M&A Strategies: Deal assessments, trends and future prospects
Successful Pharmabiotech Alliance Strategies
Pharmaceutical Strategic Alliances
Pharmaceutical Licensing Strategies
Pharmaceutical Outsourcing Strategies
Pharmaceutical Strategic Alliances: Benchmarking 21st century deal-making
The Pharmaceutical Licensing Outlook: effective deal-making and profitable partnerships
The Pharmaceutical Mergers and Acquisitions Outlook 2001
Pharmaceutical Mergers & Acquisitions: the third wave
The Pharmaceutical Outsourcing Outlook 1998-2003

NEW THERAPEUTIC AREAS
Immunosuppressants, Organ Transplants, and the Potential of Regenerative Medicine
The Gastrointestinal Market Outlook To 2014
The Diabetes Market Outlook To 2014
The Ophthalmic Pharmaceutical Market Outlook To 2014
The Autoimmune Outlook to 2013
The Dermatology Market Outlook to 2013
Innovations, Products and Pipelines for Respiratory Disorders
Innovations in The Management of Diabetes: Next generation treatments and market dynamics
The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
The Gastrointestinal Market Outlook to 2012
Autoimmune Market Outlook to 2012
The Dermatology Market Outlook to 2011
The Future of Monoclonal Antibodies Therapeutics
The Asthma, COPD & Allergic Rhinitis Market Outlook to 2011
The Diabetes Market Outlook to 2011
The Gastrointestinal Market Outlook to 2010
The Asthma and COPD Market Outlook

JAPANESE PHARMACEUTICAL MARKET
The Japanese Pharmaceutical Market Outlook to 2014
The Japanese Pharmaceutical Companies Outlook
The Japanese Pharmaceutical Market Outlook 2001



The Cardiovascular Market Outlook to 2015
The Cardiovascular Market Outlook to 2014
The Cardiovascular Market Outlook to 2013
The Cardiovascular Disorders Market Outlook to 2012
Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs
Innovations in Cardiovascular Disease Management
The Cardiovascular Market Outlook to 2011
The Asian Cardiovascular Market Outlook to 2010
The Latin American Cardiovascular Market Outlook to 2010
The Eastern European Cardiovascular Market Outlook to 2010
The Cardiovascular Market Outlook to 2010
The Diabetes Market Outlook: Market analysis of future growth and leading players by sector
The Cardiovascular Market Outlook to 2009
The Outlook for Cardiovascular Risk Factors: Epidemiology, market and pipeline analysis
The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being
The Cardiovascular Market Outlook to 2008
The Cardiovascular Outlook to 2007
The Lifestyle Drugs Outlook To 2007: Challenges and opportunities in a high-profile growth market
The Cardiovascular Outlook 2000
The Cardiovascular Outlook 1998-2010
Lifestyle Drugs Outlook to 2005



The CNS Market Outlook to 2014
The Pain Management Market Outlook To 2014
The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
The CNS Market Outlook to 2012
Innovations in CNS: Novel therapeutics and future R&D strategies
The CNS Market Outlook to 2011
The Pain Market Outlook to 2011
The CNS Market Outlook to 2010
The CNS Market Outlook to 2009
The Outlook for Niche CNS Disorders
Commercial Opportunities from an Aging Population
The CNS Market Outlook to 2008
The CNS Outlook to 2007
The CNS Outlook 2000
Pain Therapeutics: A Strategic Re-evaluation.
Antisense Therapy: Technical Aspects and Commercial Opportunities
The CNS Outlook 1998-2010




eHealth Solutions for Pharma
Harnessing Patient Power
Consumer-Targeted Internet Investment
Physician-Targeted Internet Promotion
The Outlook for eR&D Strategies
Measuring eBusiness In the Pharmaceutical Sector
The Outlook For Direct-To-Consumer Marketing: Maximizing The Return On Your Investment
Advertising medicines and providing health information on the Internet
The Outlook For Direct-To-Consumer Marketing Vol II: Maximizing online potential
Patient Power Outlook 2001
eHealth Tools and eHealth Management: Opportunities and challenges for pharma companies and MCOs
eHealth Connectivity: Linking Players, Providers and Patients
eHealth Content: An analysis of healthcare Information on the Internet
ePharmacies: Strategic Implications for the Healthcare Industry
Patient Power in the Pharmaceutical Industry



The Vaccines Market Outlook To 2014
The Anti-Infectives Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
The Global HIV/AIDS Market Outlook to 2012
The Global Anti-Infectives Market Outlook to 2011
The Vaccines Market Outlook: Market analysis of future growth and leading players by sector
The Antivirals Market Outlook: Market analysis of future growth and leading players by sector
The Antivirals Outlook to 2007



The Cancer Market Outlook To 2015
The Cancer Market Outlook To 2014
Launching Next Generation Oncology Products: Evolving Strategies in a Payor’s Market
The Cancer Market Outlook to 2013
The Cancer Market Outlook to 2012
Innovative and Targeted Cancer Therapies
The Cancer Market Outlook to 2011
The Eastern European Cancer Market Outlook to 2010
The Asian Cancer Market Outlook to 2010
The Latin American Cancer Market Outlook to 2010
The Cancer Market Outlook to 2010
The Cancer Market Outlook to 2009
Targeted Cancer Therapies: Innovative drugs and their impact on the future of oncology
The Cancer Market Outlook to 2008
New Cancer Therapeutics: An analysis of current and emerging markets
The Cancer Outlook to 2007
The Cancer Outlook 2000
The Cancer Market Outlook 1998-2010



Pharma Pricing and Reimbursement Outlook
Valuing Pharmaceutical Innovation: Pricing and reimbursement for innovative therapies
Pharmaceutical Pricing and Reimbursement
Pharmaceutical Pricing Strategies 2005
Pharmaceutical Pricing Strategies: Optimizing returns throughout R&D and marketing
Cost Effective Healthcare Solutions; The Strategic Impact of Pharmacoeconomics in Key Markets
Bridging the Pharmaceutical Earnings gap: Key Strategies in the race for growth
Pharmaceutical Pricing Strategies 2000: Entering the new millennium
Pharmaceutical Pricing Strategies



Click here for more information on the Drug Discovery series




Click here for more information on the Pharmaceutical Outsourcing Series

Click here for more information on the Diagnostics Series

Dyslipidemia: Opportunities in Cardiovascular risk reduction
Apoptosis: Opportunities in Cancer and Other Diseases